Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Posner Christopher
PRESIDENT AND CEO at Tvardi Therapeutics. Filing since 19 Nov 2020.
CIK 0001748265
Company
Date
Role
Action
Shares
Amount
Of holding
TVRD
Tvardi Therapeutics, Inc.
28 Feb 2025
PRESIDENT AND CEO
Sold at will
583
$2.77K
4.3%
TVRD
Tvardi Therapeutics, Inc.
4 Feb 2025
PRESIDENT AND CEO
Sold at will
372
$1.76K
2.6%
TVRD
Tvardi Therapeutics, Inc.
4 Nov 2024
PRESIDENT AND CEO
Sold at will
3,668
$1.06K
2.1%
TVRD
Tvardi Therapeutics, Inc.
1 Aug 2024
PRESIDENT AND CEO
Sold at will
4,149
$1.45K
2.3%
TVRD
Tvardi Therapeutics, Inc.
2 May 2024
PRESIDENT AND CEO
Sold at will
3,936
$2.95K
2.2%
TVRD
Tvardi Therapeutics, Inc.
29 Feb 2024
PRESIDENT AND CEO
Sold at will
5,834
$5.19K
3.1%
TVRD
Tvardi Therapeutics, Inc.
8 Feb 2024
PRESIDENT AND CEO
Sold at will
35,575
$18.85K
16.0%
TVRD
Tvardi Therapeutics, Inc.
1 Feb 2024
PRESIDENT AND CEO
Sold at will
4,981
$2.74K
2.2%
TVRD
Tvardi Therapeutics, Inc.
2 Nov 2023
President and CEO
Sold at will
3,796
$4.63K
2.3%
TVRD
Tvardi Therapeutics, Inc.
3 Aug 2023
President and CEO
Sold on a plan
4,307
$13.22K
2.5%
TVRD
Tvardi Therapeutics, Inc.
5 May 2023
President and CEO
Sold on a plan
3,869
$17.02K
2.2%
TVRD
Tvardi Therapeutics, Inc.
3 Mar 2023
President and CEO
Sold, plan not stated
5,987
$58.13K
3.3%
TVRD
Tvardi Therapeutics, Inc.
2 Feb 2023
President and CEO
Sold, plan not stated
4,191
$49.45K
2.2%
TVRD
Tvardi Therapeutics, Inc.
16 Nov 2022
President and CEO
Sold, plan not stated
14,470
$161.05K
7.2%
TVRD
Tvardi Therapeutics, Inc.
4 Apr 2022
President and CEO
Sold, plan not stated
2,006
$25.42K
1.0%
TVRD
Tvardi Therapeutics, Inc.
7 Jun 2021
Director
Sold, plan not stated
2,304
$30.04K
12.5%
TVRD
Tvardi Therapeutics, Inc.
19 Nov 2020
Director
Sold, plan not stated
2,000
$31.64K
15.2%
17 decisions on file.
